Abstract:Objective: To systematically evaluate the methodological quality and reporting quality of randomized controlled trials (RCT) on the treatment of BPH with traditional Chinese medicine (TCM), in order to provide some methodological reference for clinical practice and research. Methods: We searched CNKI, VIP, Wanfang Data and PubMed for RCTs on the treatment of BPH with TCM published in China from January 2013 to November 2023. Two researchers screened the literature separately, and evaluated the methodological and reporting quality of the RCTs based on the Cochrane bias risk assessment tool and CONSORT TCM compound. Results: Totally, 88 RCTs were included in this study. In terms of methodological quality, according to the Cochrane bias risk assessment tool, 27 biases in the process of randomization were identified as of low-risk and the other 61 of a certain risk. Among the allocation-related biases deviating from the established interventions, 76 were of low risk, 10 of a certain risk and 2 of high risk; among the compliance-related biases deviating from the established interventions, 76 were of low risk and 12 of a certain risk; among the biases due to missing outcome data, 86 were of low risk and 2 of a certain risk, while all the biases due to outcome measurement were of low risk; and among the biases from selective reporting, 65 were of low-risk, 2 of a certain risk and 21 of high-risk. In terms of reporting quality, according to the evaluation criteria of consort TCM compound, appropriate key words were used in 1 RCT (0.01%), the random assignment sequence method described in 27 (30.68%), the details of assignment limitation given in 5 (5.68%), assignment concealment mentioned in 3 (3.41%), the blind method and assignment concealment employed in 3 (3.41%), fall-offs recorded in 10 (11.36%), adverse events reported in 38 (43.18%), and limitations of the trials analyzed in 18 (20.45%). All the RCTs lacked complete intervention measures, subject flow chart, clinical trial registration and research schemes. Conclusion: At present, the methodological quality and reporting quality of RCTs on the treatment of BPH with TCM are generally low, with the main problems of incomplete experimental designs, lack of detailed description of randomized and blind methods, and insufficient TCM symptom evaluation of outcome indicators. Researchers should be cautious in adopting and applying the results reported, follow the CONSORT statement in design, registration, implement and reporting of the scheme, fully consider the clinical characteristics of TCM in the treatment of BPH, and reasonably design and report the evaluation indicators.

Evaluation of Clinical Literature Quality of Chinese Medicine in Treating Pancreatic Cancer

Traditional Chinese Medicine in Cancer Care: A Review of Case Reports Published in Chinese Literature

Analyzing the TCM Syndromes of Pancreatic Cancer

Guidelines for the Diagnosis and Treatment of Pancreatic Cancer in China (2021)

Study on the treatment of pancreatic cancer with integrated traditional Chinese and Western medicine

Traditional Chinese Medicine in Cancer Care: An Overview of 5834 Randomized Controlled Trials Published in Chinese

Advances in the treatment of pancreatic cancer with traditional Chinese medicine

Advances of integrated traditional and western medicine in nonsurgical treatment of pancreatic cancer

Study on Chinese Medicine Combined with Chemotherapy for Treatment of 32 Cases of Advanced Pancreatic Cancer

Therapeutic Evaluation on Advanced Pancreatic Cancer Treated by Integrative Chinese and Western Medicine — Clinical Analysis of 56 Cases

Traditional Chinese Medicine in Cancer Care: Perspectives and Experiences of Patients and Professionals in China

Recent Advances in Basic Research, Clinical Diagnosis and Treatment of Pancreatic Cancer in 2015

Bibliometrics Analysis of Traditional Chinese Medicine of Tumor

Discussion for the Clinical Definition of Pancreatic Cancer in China

[Methodological and reporting quality of randomized controlled trials on the treatment of benign prostatic hyperplasia with traditional Chinese medicine]

An Overview of Pancreatic Cancer Diagnosis and Treatment in China: Current Landscape and Future Prospects

Quality Assessment for Randomized Controlled Trials of TCM Therapy for Non-small Cell Lung Cancer

Progress in the Treatment of Gastric Cancer by Traditional Chinese Medicine

Advances and Comments on Traditional Chinese Medicine Syndrome and Treatment on Pancreatic Cancer

The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012

Recent Highlights of Experimental Research for Inhibiting Tumor Growth by Using Chinese Medicine